Author: Ferrari M.D.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.13, Iss.6, 1998-06, pp. : 667-676
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The Burden of Migraine in Spain: Beyond Direct Costs
By Badia X.
PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. :
Economic burden of osteoarthritis in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 596, 2010-01 ,pp. :
Economic Burden of Psoriatic Arthritis
By Ackermann Christoph Kavanaugh Arthur
PharmacoEconomics, Vol. 26, Iss. 2, 2008-01 ,pp. :
Economic burden of psoriasis in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 375, 2002-01 ,pp. :
ESRD with hyperphosphataemia: an economic burden
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 505, 2006-01 ,pp. :